In contrast, immunomodulatory agents targeting sphingosine-1-phosphate receptor agonist [55], C-C chemokine receptor 2 [56], or AMP-activated protein kinase [57] protected mice against a lethal influenza viral challenge. Here, S1PR1 is linked to influenza.